First Light Asset Management, LLC
- SEC CIK
- 0001600004
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 41
- +3 vs. Q2 2025
- Portfolio value
- $1.06B
- +$289.5M (+37.5%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AXGNAxogen, Inc. | COM | 5,805,730 | $103.6M | 9.8% | +1,276,487+28.2% | Added | History |
| PHLTPerformant Healthcare Inc | COM | 11,718,612 | $90.6M | 8.5% | −1,451,769−11.0% | Reduced | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,635,816 | $88.2M | 8.3% | −657,595−15.3% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 9,927,269 | $76.6M | 7.2% | +3,080,837+45.0% | Added | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 3,355,882 | $45.6M | 4.3% | +3,355,882 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 941,516 | $39.2M | 3.7% | +77,380+9.0% | Added | History |
| HCATHealth Catalyst, Inc. | COM | 13,436,220 | $38.3M | 3.6% | +1,206,039+9.9% | Added | History |
| PVLAPalvella Therapeutics, Inc. | COM | 541,544 | $33.9M | 3.2% | +541,544 | New | History |
| TWSTTwist Bioscience Corp | COM | 1,194,883 | $33.6M | 3.2% | +249,850+26.4% | Added | History |
| LENZLENZ Therapeutics, Inc. | COM | 693,044 | $32.3M | 3.0% | +693,044 | New | History |
| ORGOOrganogenesis Holdings Inc. | COM | 7,497,911 | $31.6M | 3.0% | +720,748+10.6% | Added | History |
| ATRCAtriCure, Inc. | COM | 890,362 | $31.4M | 3.0% | −124,808−12.3% | Reduced | History |
| ANABAnaptysbio, Inc | COM | 990,161 | $30.3M | 2.9% | −2,549,432−72.0% | Reduced | History |
| SIBNSI-BONE, Inc. | COM | 1,917,903 | $28.2M | 2.7% | +166,902+9.5% | Added | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 292,657 | $28.0M | 2.6% | +112,042+62.0% | Added | History |
| IRTCiRhythm Holdings, Inc. | COM | 155,099 | $26.7M | 2.5% | −32,256−17.2% | Reduced | History |
| MDXGMimedx Group, Inc. | COM | 3,652,952 | $25.5M | 2.4% | +1,725,458+89.5% | Added | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,414,994 | $23.0M | 2.2% | −299,025−17.4% | Reduced | History |
| MASS908 Devices Inc. | COM | 2,510,496 | $22.0M | 2.1% | +1,442,883+135.2% | Added | History |
| MRUSMerus N.V. | COM | 224,080 | $21.1M | 2.0% | +224,080 | New | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 180,484 | $18.2M | 1.7% | +180,484 | New | History |
| GHGuardant Health, Inc. | COM | 280,001 | $17.5M | 1.6% | +151,133+117.3% | Added | History |
| KRMDKORU Medical Systems, Inc. | COM | 4,527,737 | $17.3M | 1.6% | −153,889−3.3% | Reduced | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 418,358 | $17.1M | 1.6% | +1,201+0.3% | Added | History |
| ADMAAdma Biologics, Inc. | COM | 1,069,233 | $15.7M | 1.5% | +117,137+12.3% | Added | History |
| IRONDisc Medicine, Inc. | COM | 231,186 | $15.3M | 1.4% | +231,186 | New | History |
| VERAVera Therapeutics, Inc. | CL A | 507,097 | $14.7M | 1.4% | −55,884−9.9% | Reduced | History |
| NPCENeuroPace Inc | COM | 1,360,071 | $14.0M | 1.3% | −20,339−1.5% | Reduced | History |
| CAICaris Life Sciences, Inc. | COM | 403,924 | $11.9M | 1.1% | −39,119−8.8% | Reduced | History |
| SLPSimulations Plus, Inc. | COM | 767,760 | $11.6M | 1.1% | +410,603+115.0% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 285,699 | $8.59M | 0.8% | −262,206−47.9% | Reduced | History |
| ABVXAbivax S.A. | SPONSORED ADS | 95,955 | $8.15M | 0.8% | +95,955 | New | History |
| SENSSenseonics Holdings, Inc. | COM | 18,007,632 | $7.85M | 0.7% | −17,700,492−49.6% | Reduced | History |
| RGENRepligen Corp | COM | 41,427 | $5.54M | 0.5% | −2,522−5.7% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 197,350 | $5.53M | 0.5% | +75,124+61.5% | Added | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 11,539 | $5.29M | 0.5% | +11,539 | New | History |
| EVHEvolent Health, Inc. | CL A | 545,282 | $4.61M | 0.4% | −193,268−26.2% | Reduced | History |
| ALHCAlignment Healthcare, Inc. | COM | 203,138 | $3.54M | 0.3% | −180,525−47.1% | Reduced | History |
| RDNTRadNet, Inc. | COM | 42,280 | $3.22M | 0.3% | −26,414−38.5% | Reduced | History |
| TECXTectonic Therapeutic, Inc. | COM | 202,393 | $3.18M | 0.3% | +202,393 | New | History |
| BFLYButterfly Network, Inc. | COM CL A | 1,127,998 | $2.18M | 0.2% | −4,337,034−79.4% | Reduced | History |
Sold out since Q2 2025 (6)
Positions held at the end of Q2 2025 that are gone from this filing.
| Security | Class | Shares in Q2 2025 | Value in Q2 2025 | % of portfolio in Q2 2025 | History |
|---|---|---|---|---|---|
| ELDNEledon Pharmaceuticals, Inc. | COM | 2,600,498 | $7.05M | 0.9% | History |
| INSMINSMED Inc | COM PAR $.01 | 62,901 | $6.33M | 0.8% | History |
| XENEXenon Pharmaceuticals Inc. | COM | 188,367 | $5.90M | 0.8% | History |
| EOLSEvolus, Inc. | COM | 520,631 | $4.80M | 0.6% | History |
| JANXJanux Therapeutics, Inc. | COM | 149,596 | $3.46M | 0.4% | History |
| LNTHLantheus Holdings, Inc. | Stock | 30,045 | $2.46M | 0.3% | History |